Literature DB >> 17984206

The NleE/OspZ family of effector proteins is required for polymorphonuclear transepithelial migration, a characteristic shared by enteropathogenic Escherichia coli and Shigella flexneri infections.

Daniel V Zurawski1, Karen L Mumy, Luminita Badea, Julia A Prentice, Elizabeth L Hartland, Beth A McCormick, Anthony T Maurelli.   

Abstract

Enteropathogenic Escherichia coli (EPEC) and Shigella flexneri are human host-specific pathogens that infect intestinal epithelial cells. However, each bacterial species employs a different infection strategy within this environmental niche. EPEC attaches to the apical surface of small intestine enterocytes, causing microvillus effacement and rearrangement of the host cell cytoskeleton beneath adherent bacteria. In contrast, S. flexneri invades the large intestine epithelium at the basolateral membrane, replicates, and spreads cell to cell. Both EPEC and S. flexneri rely on type three secretion systems (T3SS) to secrete effectors into host cells, and both pathogens recruit polymorphonuclear leukocytes (PMNs) from the submucosa to the lumen of the intestine. In this report, we compared the virulence functions of the EPEC T3SS effector NleE and the homologous Shigella protein Orf212. We discovered that Orf212 was secreted by the S. flexneri T3SS and renamed this protein OspZ. Infection of polarized T84 intestinal epithelial cells with an ospZ deletion mutant of S. flexneri resulted in reduced PMN transepithelial migration compared to infection by the wild type. An nleE deletion mutant of EPEC showed a similar reduction of PMN migration. The ability to induce PMN migration was restored in both mutants when either ospZ or nleE was expressed from a plasmid. An infection of T84 cells with the delta ospZ mutant resulted in reduced extracellular signal-related kinase phosphorylation and NF-kappaB activation compared to infection with the wild type. Therefore, we conclude that OspZ and NleE have similar roles in the upstream induction of host signaling pathways required for PMN transepithelial migration in Shigella and EPEC infections.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17984206      PMCID: PMC2223660          DOI: 10.1128/IAI.00684-07

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  55 in total

Review 1.  Microbes and microbial toxins: paradigms for microbial-mucosal interactions III. Shigellosis: from symptoms to molecular pathogenesis.

Authors:  P J Sansonetti
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2001-03       Impact factor: 4.052

Review 2.  Mechanism of action of EPEC type III effector molecules.

Authors:  Brendan Kenny
Journal:  Int J Med Microbiol       Date:  2002-02       Impact factor: 3.473

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  The phosphothreonine lyase activity of a bacterial type III effector family.

Authors:  Hongtao Li; Hao Xu; Yan Zhou; Jie Zhang; Chengzu Long; Shuqin Li; She Chen; Jian-Min Zhou; Feng Shao
Journal:  Science       Date:  2007-02-16       Impact factor: 47.728

5.  Global burden of Shigella infections: implications for vaccine development and implementation of control strategies.

Authors:  K L Kotloff; J P Winickoff; B Ivanoff; J D Clemens; D L Swerdlow; P J Sansonetti; G K Adak; M M Levine
Journal:  Bull World Health Organ       Date:  1999       Impact factor: 9.408

6.  PtdIns5P activates the host cell PI3-kinase/Akt pathway during Shigella flexneri infection.

Authors:  Caroline Pendaries; Hélène Tronchère; Laurence Arbibe; Joelle Mounier; Or Gozani; Lewis Cantley; Michael J Fry; Frédérique Gaits-Iacovoni; Philippe J Sansonetti; Bernard Payrastre
Journal:  EMBO J       Date:  2006-02-16       Impact factor: 11.598

7.  Loss of pigmentation in Shigella flexneri 2a is correlated with loss of virulence and virulence-associated plasmid.

Authors:  A T Maurelli; B Blackmon; R Curtiss
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

8.  Studies on transformation of Escherichia coli with plasmids.

Authors:  D Hanahan
Journal:  J Mol Biol       Date:  1983-06-05       Impact factor: 5.469

Review 9.  Pathogenic Escherichia coli.

Authors:  James B Kaper; James P Nataro; Harry L Mobley
Journal:  Nat Rev Microbiol       Date:  2004-02       Impact factor: 60.633

10.  Lambda Red-mediated recombinogenic engineering of enterohemorrhagic and enteropathogenic E. coli.

Authors:  Kenan C Murphy; Kenneth G Campellone
Journal:  BMC Mol Biol       Date:  2003-12-13       Impact factor: 2.946

View more
  24 in total

1.  Prevalence and characteristics of the O122 pathogenicity island in typical and atypical enteropathogenic Escherichia coli strains.

Authors:  Mônica A M Vieira; Fábia A Salvador; Rosa M Silva; Kinue Irino; Tânia M I Vaz; Anna C Rockstroh; Beatriz E C Guth; Tânia A T Gomes
Journal:  J Clin Microbiol       Date:  2010-02-24       Impact factor: 5.948

2.  The Type III Effector NleD from Enteropathogenic Escherichia coli Differentiates between Host Substrates p38 and JNK.

Authors:  Kristina Creuzburg; Cristina Giogha; Tania Wong Fok Lung; Nichollas E Scott; Sabrina Mühlen; Elizabeth L Hartland; Jaclyn S Pearson
Journal:  Infect Immun       Date:  2017-01-26       Impact factor: 3.441

3.  A distinct regulatory sequence is essential for the expression of a subset of nle genes in attaching and effacing Escherichia coli.

Authors:  Víctor A García-Angulo; Verónica I Martínez-Santos; Tomás Villaseñor; Francisco J Santana; Alejandro Huerta-Saquero; Luary C Martínez; Rafael Jiménez; Cristina Lara-Ochoa; Juan Téllez-Sosa; Víctor H Bustamante; José L Puente
Journal:  J Bacteriol       Date:  2012-08-17       Impact factor: 3.490

4.  Identification of a Distinct Substrate-binding Domain in the Bacterial Cysteine Methyltransferase Effectors NleE and OspZ.

Authors:  Ying Zhang; Sabrina Mühlen; Clare V Oates; Jaclyn S Pearson; Elizabeth L Hartland
Journal:  J Biol Chem       Date:  2016-07-21       Impact factor: 5.157

Review 5.  Pathogenesis of human enterovirulent bacteria: lessons from cultured, fully differentiated human colon cancer cell lines.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Microbiol Mol Biol Rev       Date:  2013-09       Impact factor: 11.056

6.  Characterization of the ospZ promoter in Shigella flexneri and its regulation by VirB and H-NS.

Authors:  David W Basta; Krystle L Pew; Joy A Immak; Hiromichi S Park; Michael A Picker; Amanda F Wigley; Christopher T Hensley; Jaclyn S Pearson; Elizabeth L Hartland; Helen J Wing
Journal:  J Bacteriol       Date:  2013-03-29       Impact factor: 3.490

7.  The type III secretion effector NleE inhibits NF-kappaB activation.

Authors:  Chen Nadler; Kobi Baruch; Simi Kobi; Erez Mills; Gili Haviv; Marganit Farago; Irit Alkalay; Sina Bartfeld; Thomas F Meyer; Yinon Ben-Neriah; Ilan Rosenshine
Journal:  PLoS Pathog       Date:  2010-01-29       Impact factor: 6.823

8.  The type III effectors NleE and NleB from enteropathogenic E. coli and OspZ from Shigella block nuclear translocation of NF-kappaB p65.

Authors:  Hayley J Newton; Jaclyn S Pearson; Luminita Badea; Michelle Kelly; Mark Lucas; Gavan Holloway; Kylie M Wagstaff; Michelle A Dunstone; Joan Sloan; James C Whisstock; James B Kaper; Roy M Robins-Browne; David A Jans; Gad Frankel; Alan D Phillips; Barbara S Coulson; Elizabeth L Hartland
Journal:  PLoS Pathog       Date:  2010-05-13       Impact factor: 6.823

Review 9.  The role of neutrophils in the event of intestinal inflammation.

Authors:  Karen L Mumy; Beth A McCormick
Journal:  Curr Opin Pharmacol       Date:  2009-10-24       Impact factor: 5.547

10.  The Shigella dysenteriae serotype 1 proteome, profiled in the host intestinal environment, reveals major metabolic modifications and increased expression of invasive proteins.

Authors:  Rembert Pieper; Quanshun Zhang; Prashanth P Parmar; Shih-Ting Huang; David J Clark; Hamid Alami; Arthur Donohue-Rolfe; Robert D Fleischmann; Scott N Peterson; Saul Tzipori
Journal:  Proteomics       Date:  2009-11       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.